Author： Lv Qiao-Li Hu Lei Chen Shu-Hui Sun Bao Fu Meng-Long Qin Chong-Zhen Qu Qiang Wang Gui-Hua He Chen-Jie Zhou Hong-Hao
Publisher： MDPI
E-ISSN： 1422-0067|17|9|1431-1431
ISSN： 1422-0067
Source： International Journal of Molecular Sciences, Vol.17, Iss.9, 2016-08, pp. : 1431-1431
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Emerging studies show that long noncoding RNAs (lncRNAs) have important roles in carcinogenesis. lncRNA ZEB1 antisense 1 (ZEB1-AS1) is a novel lncRNA, whose clinical significance, biological function, and underlying mechanism remains unclear in glioma. Here, we found that ZEB1-AS1 was highly expressed in glioma tissues, being closely related to clinical stage of glioma. Moreover, patients with high ZEB1-AS1 levels had poor prognoses, with the evidence provided by multivariate Cox regression analysis indicating that ZEB1-AS1 expression could serve as an independent prognostic factor in glioma patients. Functionally, silencing of ZEB1-AS1 could significantly inhibit cell proliferation, migration, and invasion, as well as promote apoptosis. Knockdown of ZEB1-AS1 significantly induced the G0/G1 phase arrest and correspondingly decreased the percentage of S phase cells. Further analysis indicated that ZEB1-AS1 could regulate the cell cycle by inhibiting the expression of G1/S transition key regulators, such as Cyclin D1 and CDK2. Furthermore, ZEB1-AS1 functioned as an important regulator of migration and invasion via activating epithelial to mesenchymal transition (EMT) through up-regulating the expression of ZEB1, MMP2, MMP9, N-cadherin, and Integrin-β1 as well as decreasing E-cadherin levels in the metastatic progression of glioma. Additionally, forced down-regulation of ZEB1-AS1 could dramatically promote apoptosis by increasing the expression level of Bax and reducing Bcl-2 expression in glioma. Taken together, our data suggest that ZEB1-AS1 may serve as a new prognostic biomarker and therapeutic target of glioma.
Related content
Access to resources
Recommend
By Ding Li-Juan Li Yan Wang Shu-Dong Wang Xin-Sen Fang Fang Wang Wei-Yao Lv Peng Zhao Dong-Hai Wei Feng Qi Ling
International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-09 ,pp. :